Senolytic Therapy to Modulate Progression of Alzheimer's Disease
Condition: Alzheimer Disease Intervention: Drug: Dasatinib + Quercetin Sponsors: The University of Texas Health Science Center at San Antonio; Mayo Clinic Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials